|
PRPF4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.168700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.587760E-04 |
| Normal-vs-Stage2 |
1.819600E-01 |
| Normal-vs-Stage3 |
7.143800E-03 |
| Normal-vs-Stage4 |
2.639800E-03 |
| Stage1-vs-Stage2 |
5.146200E-01 |
| Stage1-vs-Stage3 |
9.460200E-01 |
| Stage1-vs-Stage4 |
6.950000E-01 |
| Stage2-vs-Stage3 |
5.409000E-01 |
| Stage2-vs-Stage4 |
4.449800E-01 |
| Stage3-vs-Stage4 |
7.056400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.834720E-04 |
| Normal-vs-AfricanAmerican |
1.294340E-02 |
| Normal-vs-Asian |
4.341400E-03 |
| Caucasian-vs-AfricanAmerican |
5.864600E-01 |
| Caucasian-vs-Asian |
5.612800E-01 |
| AfricanAmerican-vs-Asian |
4.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5797699999931E-05 |
| Normal-vs-Female |
3.479600E-01 |
| Male-vs-Female |
8.060600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.477700E-03 |
| Normal-vs-Extreme_Weight |
1.30890000005213E-06 |
| Normal-vs-Obese |
4.642100E-02 |
| Normal-vs-Extreme_Obese |
1.238390E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.192000E-01 |
| Normal_Weight-vs-Obese |
3.301200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.343800E-01 |
| Extreme_Weight-vs-Obese |
1.405750E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.192600E-01 |
| Obese-vs-Extreme_Obese |
4.327200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.998800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.690000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.51039999999325E-05 |
| Normal-vs-Age(81-100Yrs) |
1.56497999999061E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.884800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.113700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.177100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.301200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.521600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.690650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.960510E-03 |
| Normal-VS-Type2 PRCC |
7.97979999966891E-07 |
| Normal-VS-KIRP CIMP |
2.831400E-01 |
| Normal-VS-Unclassified PRCC |
2.262000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.134050E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.881800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.330800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.563400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.057600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.878000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.9868999996725E-07 |
| Normal-vs-N1 |
2.873200E-01 |
| Normal-vs-N2 |
2.169500E-04 |
| N0-vs-N1 |
2.639800E-02 |
| N0-vs-N2 |
2.667800E-01 |
| N1-vs-N2 |
7.933900E-02 |
|
|
